These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1013701

  • 1. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR, Gavras H.
    Schweiz Med Wochenschr; 1976 Dec 11; 106(50):1791-8. PubMed ID: 1013701
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO, Kolloch RE, Redlich B, Vetter H, Krück F.
    Verh Dtsch Ges Kreislaufforsch; 1977 Dec 11; 43():167-76. PubMed ID: 613561
    [No Abstract] [Full Text] [Related]

  • 6. Angiotensin inhibitors for hypertension.
    Gavras H, Gavras I, Brunner HR.
    Compr Ther; 1980 May 11; 6(5):14-8. PubMed ID: 6155240
    [Abstract] [Full Text] [Related]

  • 7. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH, Case DB, Wallace JM, Keim H.
    Fed Proc; 1977 Apr 11; 36(5):1781-7. PubMed ID: 191300
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Editorial: New prospects in renal hypertension.
    Br Med J; 1975 Jul 12; 3(5975):59-60. PubMed ID: 1139228
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO, Kolloch RE, Overlack A.
    Med Welt; 1977 Oct 14; 28(41):1645-9. PubMed ID: 927124
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M, Bichara M, Grüfeld JP, Barbanel C, Meyer P, Funck-Brentano JL.
    Nouv Presse Med; 1978 Feb 18; 7(7):539-43. PubMed ID: 643579
    [Abstract] [Full Text] [Related]

  • 15. Editorial: Mechanisms in hypertension.
    Lancet; 1975 Sep 06; 2(7932):445. PubMed ID: 51247
    [No Abstract] [Full Text] [Related]

  • 16. Angiotensin blockade in hypertension.
    Streeten DH, Anderson GH.
    Ann Intern Med; 1977 Mar 06; 86(3):353-4. PubMed ID: 842997
    [No Abstract] [Full Text] [Related]

  • 17. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH.
    Adv Nephrol Necker Hosp; 1979 Mar 06; 8():297-319. PubMed ID: 115245
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA, Niarchos AP, Case DB.
    Am J Nephrol; 1983 Mar 06; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract] [Full Text] [Related]

  • 19. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
    Mimran A, Deschodt G, Shaldon S, Barjon P, Mion C.
    Arch Mal Coeur Vaiss; 1978 Jul 06; 71 Spec No():19-24. PubMed ID: 101176
    [Abstract] [Full Text] [Related]

  • 20. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J, Germakowska-Kowalik T, Pluta S.
    Postepy Hig Med Dosw; 1982 Jul 06; 35(4):395-411. PubMed ID: 6183653
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.